Boehringer-ingelheim.com

FDA Approves Jardiance® (empagliflozin) for Heart …

WEBRidgefield, Conn. and Indianapolis, August 18, 2021 – Jardiance® (empagliflozin) 10 mg has been approved by the U.S. Food and Drug Administration to reduce the risk of …

Actived: 1 days ago

URL: https://www.boehringer-ingelheim.com/us/us-fda-approves-jardiancer-empagliflozin-treat-adults-living-heart-failure-reduced-ejection

Our Company Corporate Profile Boehringer Ingelheim US

WEBBoehringer Ingelheim. We have been transforming lives in healthcare since 1885. Our 53,000 employees in 130 markets create value through innovation by infusing long-term, …

Category:  Health Go Health

Mental Disorders Boehringer Ingelheim

WEBBy combining traditional treatment approaches with new and innovative approaches and technologies, we will enable those with mental health conditions such as Schizophrenia, …

Category:  Health Go Health

Fully Testing For Chronic Kidney Disease IT TAKES 2

WEBIt Takes 2 – Remixing the ‘80’s Hit for Kidney Health Awareness. Rob Base may have said it best: “It takes two to make a thing go right” – and that applies to your patients’ kidney …

Category:  Health Go Health

Boehringer Ingelheim

WEBPartner with us. Partnerships are the lifeblood of our organization. We cultivate partnerships that push our clinical boundaries further in the pursuit of disruptive ideas, compounds …

Category:  Health Go Health

Boehringer Ingelheim Careers Explore Job Opportunities

WEBDiscover a world of opportunities at Boehringer Ingelheim. Join our team and contribute to improving human and animal health worldwide.

Category:  Health Go Health

Boehringer included on LinkedIn’s “Top Companies 2024” list

WEBFresh off the Annual Press Conference in Ingelheim, Germany, Boehringer Ingelheim was honored as one of LinkedIn’s Top Companies 2024 list in the U.S., comprised of …

Category:  Health Go Health

Identifying Risk Factors to Improve Outcomes in Chronic Kidney …

WEBType 2 diabetes and high blood pressure are leading causes of kidney failure, accounting for 3 out of 4 new cases. Primary Care Providers and Endocrinologists are uniquely …

Category:  Health Go Health

Boehringer Ingelheim reports strong growth in 2023 and …

WEBIngelheim am Rhein - Boehringer Ingelheim today announced a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as planned. …

Category:  Health Go Health

Low-WAC interchangeable biosimilar is now available

WEBRidgefield, Conn., October 2, 2023 – Boehringer Ingelheim announced today that Adalimumab-adbm injection, the company’s interchangeable* biosimilar to Humira ® …

Category:  Health Go Health

More Health: For People & Animals Boehringer Ingelheim

WEBTackling NCDs through innovation AND collaboration. Non-communicable diseases are a significant medical, humanitarian and socio-economic issue. Rapid innovation and …

Category:  Medical Go Health

BI Launches Vaccine to Protect Poultry

WEBVAXXITEK® HVT+IBD+ILT is the first vaccine to offer protection in one shot from Infectious Laryngotracheitis, Marek’s Disease and Infectious Bursal Disease. DULUTH, Ga. (Oct. …

Category:  Health Go Health

Boehringer Ingelheim strong growth pipeline acceleration 2023

WEBR&D expenditures increase by 14.2% to EUR 5.8 bn. Boehringer Ingelheim today announced a strong acceleration of its pipeline in 2023, as pivotal trials in key research …

Category:  Health Go Health

Animal Health & Veterinary Medicine Boehringer Ingelheim US

WEBWe prevent disease. We champion innovation. And we cherish the bond that people and animals share. At Boehringer Ingelheim Animal Health USA Inc. our passion revolves …

Category:  Health Go Health

Get in Touch Contact Us Boehringer Ingelheim US

WEBBoehringer Ingelheim Pharmaceuticals, Inc. 900 Ridgebury Road Ridgefield, CT 06877 Phone: 1-800-243-0127 (toll free) Fax: 203-791-6234. Boehringer Ingelheim Animal …

Category:  Health Go Health

Discover our Careers Boehringer Ingelheim Careers

WEBEarly careers. Emerging talent – your future with us, our future with you. Learn about the various careers we offer, designed to help you grow professionally, while also providing …

Category:  Health Go Health

Investigational Compound Granted FDA Orphan Drug Designation

WEBRidgefield, Conn., November 10, 2023 | Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BI …

Category:  Food Go Health

Patient Assistance Program Boehringer Ingelheim

WEBHuman Health Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacturing and marketing of innovative health care …

Category:  Health Go Health

Boehringer acquires T3 Pharma Boehringer Ingelheim

WEBBoehringer Ingelheim today announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 …

Category:  Health Go Health

BI Cares Patient Assistance Portal Boehringer Ingelheim US

WEBFor assistance with our program, please call our toll-free number Monday – Friday from 8:30 a.m. – 6:00 p.m. Eastern time: BI Cares Patient Assistance Program (includes a …

Category:  Health Go Health

Companion Animals, House Pets and Equines Boehringer Ingelheim

WEBWith a strong presence in the companion animal and livestock segments, we support veterinarians, farmers as well as pet and horse owners. As part of family-owned …

Category:  Health Go Health

BI Cares: Strengthening Communities Boehringer Ingelheim US

WEBOnly programs aligned with our goals will be considered. Our geographic focus is communities around Boehringer Ingelheim US sites. bicares.boehringer-ingelheim.com …

Category:  Health Go Health